AVJ16

CAS No. 2775241-92-2

AVJ16( —— )

Catalog No. M37707 CAS No. 2775241-92-2

AVJ16 as a member of the insulin growth factor 2 mRNA-binding protein family, binds to the mRNA of certain genes to regulate protein translation.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 340 In Stock
5MG 330 In Stock
10MG 527 In Stock
25MG 852 In Stock
50MG 1144 In Stock
100MG 1535 In Stock
200MG 2065 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    AVJ16
  • Note
    Research use only, not for human use.
  • Brief Description
    AVJ16 as a member of the insulin growth factor 2 mRNA-binding protein family, binds to the mRNA of certain genes to regulate protein translation.
  • Description
    AVJ16 is a cancer cell migration inhibitor that targets the insulin-like growth factor 2 mRNA binding protein IGF2BP1 to inhibit the migration of H1299 cells with high endogenous IGF2BP1 expression. AVJ16 interferes with IGF2BP1 binding target mRNA to regulate gene expression and translation.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    IGF-2R
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2775241-92-2
  • Formula Weight
    469.53
  • Molecular Formula
    C28H27N3O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 250 mg/mL (532.45 mM; Ultrasonic )
  • SMILES
    OCC1=CC(C=CC=C2)=C2N1CC(C=C3)=CC=C3C(N(CC4)CCN4C(C=C5)=CC6=C5OCO6)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Singh A, et al. Development of a Novel IGF2BP1 Inhibitor as Metastasis-Specific Therapeutic Agent[J]. European Journal of Cancer, 2022, 174: S104-S105.
molnova catalog
related products
  • Peltatoside

    Peltatoside is a natural product.

  • Xenopsin-Related Pep...

    Xenin-8, a C-terminal octapeptide, is a biologically active fragment of Xenin. Xenin is a 25-amino acid peptide of the neurotensin/xenopsin family. Xenin-8 stimulates basal insulin secretion and potentiates the insulin response to glucose in a dose-dependent manner (EC50=0.16 nM).

  • BAM (8-22)

    Endogenous peptide fragment that is a potent agonist for MRGPRX1 (EC50 values are 8 - 150 nM); first isolated from bovine adrenal medulla. Unlike BAM 22P , does not contain the met-enkephalin motif therefore displays no affinity for opioid receptors.